Interestingly, wild-type and mutant forms of ALK have been shown to induce transcription of MYC in NB and NSCLC cell lines; this may explain the poor prognosis of NB patients harbouring both ALK mutations and MYCN amplification [64,79]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.